News

The proposed acquisition is worth $2 billion and will boost Hospira’s place in generic injectable pharmaceuticals when it gains Mayne Pharma’s pipeline of products. “Following the combination of

The study by Johns Hopkins Kimmel Cancer Center found that the pairing of cholesterol-lowering lovastatin and cyclopamine killed 63% of medulloblastoma cells. By contrast, using either agent alone

Merck originally took the painkiller Vioxx off the market in 2004 after reports that the drug could cause an increase risk of heart attacks. The company believes that

As a result, Adherex will assume full direction over the product's future development pursuant to the terms of the license, including the ability to partner and sub-license the

GenVec's technology is used for the production of recombinant adenovirus vaccine vectors. GenVec has been collaborating with the Naval Medical Research Center for the past four years to

Exforge combines in one tablet the power of the two most commonly prescribed branded hypertension medicines, Diovan and Norvasc. Exforge is indicated for the treatment of hypertension in

The findings to date indicate that PRX302 is well tolerated and shows encouraging signs of therapeutic activity following a single intra-prostatic injection. This trial is intended to examine

The phase IIa trial examined two doses of AZ-004, 5 and 10 mg, and placebo. The primary aim of the trial was to assess the safety and efficacy

However, the product candidate 1207 did achieve the primary endpoint of safety and tolerability. In addition to safety data, the study measured sensory perceptions of touch and warmth